- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.65 Å
- Oligo State
- homo-trimer
- Ligands
- 6 x ZN: ZINC ION(Non-covalent)
ZN.1: 6 residues within 4Å:- Chain A: H.87, H.91, H.125, D.126, D.236
- Ligands: ZN.2
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:H.91, A:H.125, A:D.126, A:D.236
ZN.2: 3 residues within 4Å:- Chain A: H.125, D.126
- Ligands: ZN.1
5 PLIP interactions:2 interactions with chain A, 3 Ligand-Water interactions- Metal complexes: A:D.126, A:D.126, H2O.2, H2O.2, H2O.2
ZN.12: 6 residues within 4Å:- Chain B: H.87, H.91, H.125, D.126, D.236
- Ligands: ZN.13
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:H.91, B:H.125, B:D.126, B:D.236
ZN.13: 3 residues within 4Å:- Chain B: H.125, D.126
- Ligands: ZN.12
5 PLIP interactions:2 interactions with chain B, 3 Ligand-Water interactions- Metal complexes: B:D.126, B:D.126, H2O.4, H2O.4, H2O.4
ZN.23: 6 residues within 4Å:- Chain C: H.87, H.91, H.125, D.126, D.236
- Ligands: ZN.24
4 PLIP interactions:4 interactions with chain C- Metal complexes: C:H.91, C:H.125, C:D.126, C:D.236
ZN.24: 3 residues within 4Å:- Chain C: H.125, D.126
- Ligands: ZN.23
5 PLIP interactions:2 interactions with chain C, 3 Ligand-Water interactions- Metal complexes: C:D.126, C:D.126, H2O.6, H2O.6, H2O.7
- 21 x SO4: SULFATE ION(Non-functional Binders)
SO4.3: 5 residues within 4Å:- Chain A: F.44, E.45, N.46
- Chain C: R.82, R.130
Ligand excluded by PLIPSO4.4: 6 residues within 4Å:- Chain A: K.69, L.167, E.168, G.169, H.170, N.171
Ligand excluded by PLIPSO4.5: 7 residues within 4Å:- Chain A: V.84, P.85, R.130, G.131, F.132, E.257, A.260
Ligand excluded by PLIPSO4.6: 4 residues within 4Å:- Chain A: L.109, L.218, N.219, R.224
Ligand excluded by PLIPSO4.7: 2 residues within 4Å:- Chain A: R.82, R.83
Ligand excluded by PLIPSO4.8: 5 residues within 4Å:- Chain A: L.147, Y.148, S.149, T.150, Q.155
Ligand excluded by PLIPSO4.9: 4 residues within 4Å:- Chain A: N.80, Q.160, S.163, I.164
Ligand excluded by PLIPSO4.14: 5 residues within 4Å:- Chain A: R.82, R.130
- Chain B: F.44, E.45, N.46
Ligand excluded by PLIPSO4.15: 6 residues within 4Å:- Chain B: K.69, L.167, E.168, G.169, H.170, N.171
Ligand excluded by PLIPSO4.16: 7 residues within 4Å:- Chain B: V.84, P.85, R.130, G.131, F.132, E.257, A.260
Ligand excluded by PLIPSO4.17: 4 residues within 4Å:- Chain B: L.109, L.218, N.219, R.224
Ligand excluded by PLIPSO4.18: 2 residues within 4Å:- Chain B: R.82, R.83
Ligand excluded by PLIPSO4.19: 5 residues within 4Å:- Chain B: L.147, Y.148, S.149, T.150, Q.155
Ligand excluded by PLIPSO4.20: 4 residues within 4Å:- Chain B: N.80, Q.160, S.163, I.164
Ligand excluded by PLIPSO4.25: 5 residues within 4Å:- Chain B: R.82, R.130
- Chain C: F.44, E.45, N.46
Ligand excluded by PLIPSO4.26: 6 residues within 4Å:- Chain C: K.69, L.167, E.168, G.169, H.170, N.171
Ligand excluded by PLIPSO4.27: 7 residues within 4Å:- Chain C: V.84, P.85, R.130, G.131, F.132, E.257, A.260
Ligand excluded by PLIPSO4.28: 4 residues within 4Å:- Chain C: L.109, L.218, N.219, R.224
Ligand excluded by PLIPSO4.29: 2 residues within 4Å:- Chain C: R.82, R.83
Ligand excluded by PLIPSO4.30: 5 residues within 4Å:- Chain C: L.147, Y.148, S.149, T.150, Q.155
Ligand excluded by PLIPSO4.31: 4 residues within 4Å:- Chain C: N.80, Q.160, S.163, I.164
Ligand excluded by PLIP- 3 x GOL: GLYCEROL(Non-functional Binders)
GOL.10: 3 residues within 4Å:- Chain A: S.222, H.223, R.226
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:S.222
GOL.21: 3 residues within 4Å:- Chain B: S.222, H.223, R.226
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:S.222
GOL.32: 3 residues within 4Å:- Chain C: S.222, H.223, R.226
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:S.222
- 3 x 35D: 1-[4-(3-{[1-(quinolin-2-yl)azetidin-3-yl]oxy}quinoxalin-2-yl)piperidin-1-yl]ethanone(Non-covalent)
35D.11: 13 residues within 4Å:- Chain A: L.197, L.237, I.254, Y.255, F.258, P.274, M.275, K.280, E.283, V.284, G.287, Q.288, F.291
11 PLIP interactions:11 interactions with chain A- Hydrophobic interactions: A:L.197, A:L.237, A:I.254, A:Y.255, A:F.258, A:P.274, A:M.275, A:E.283, A:F.291
- Hydrogen bonds: A:Q.288
- pi-Stacking: A:F.291
35D.22: 13 residues within 4Å:- Chain B: L.197, L.237, I.254, Y.255, F.258, P.274, M.275, K.280, E.283, V.284, G.287, Q.288, F.291
12 PLIP interactions:12 interactions with chain B- Hydrophobic interactions: B:L.197, B:L.237, B:I.254, B:Y.255, B:F.258, B:P.274, B:M.275, B:E.283, B:F.291
- Hydrogen bonds: B:Y.255, B:Q.288
- pi-Stacking: B:F.291
35D.33: 13 residues within 4Å:- Chain C: L.197, L.237, I.254, Y.255, F.258, P.274, M.275, K.280, E.283, V.284, G.287, Q.288, F.291
11 PLIP interactions:11 interactions with chain C- Hydrophobic interactions: C:L.197, C:L.237, C:I.254, C:Y.255, C:F.258, C:P.274, C:M.275, C:E.283, C:F.291
- Hydrogen bonds: C:Q.288
- pi-Stacking: C:F.291
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Rzasa, R.M. et al., Synthesis and preliminary biological evaluation of potent and selective 2-(3-alkoxy-1-azetidinyl) quinolines as novel PDE10A inhibitors with improved solubility. Bioorg.Med.Chem. (2014)
- Release Date
- 2014-12-17
- Peptides
- cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.65 Å
- Oligo State
- homo-trimer
- Ligands
- 6 x ZN: ZINC ION(Non-covalent)
- 21 x SO4: SULFATE ION(Non-functional Binders)
- 3 x GOL: GLYCEROL(Non-functional Binders)
- 3 x 35D: 1-[4-(3-{[1-(quinolin-2-yl)azetidin-3-yl]oxy}quinoxalin-2-yl)piperidin-1-yl]ethanone(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Rzasa, R.M. et al., Synthesis and preliminary biological evaluation of potent and selective 2-(3-alkoxy-1-azetidinyl) quinolines as novel PDE10A inhibitors with improved solubility. Bioorg.Med.Chem. (2014)
- Release Date
- 2014-12-17
- Peptides
- cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
A